These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16230301)

  • 21. HIT on dialysis--when is it safe to re-challenge?
    Davenport A
    Nephron Clin Pract; 2006; 104(4):c149-50. PubMed ID: 16902312
    [No Abstract]   [Full Text] [Related]  

  • 22. Heparin-induced thrombocytopenia type II with pulmonary embolism after cesarean section.
    Meyberg R; Ertan AK; Axt R; Villena-Heinsen C; Schmidt W; Friedrich M
    Clin Exp Obstet Gynecol; 2000; 27(1):33-4. PubMed ID: 10758796
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonbleeding complications of unfractionated and low-molecular weight heparins.
    Eikelboom J
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):871-3. PubMed ID: 18185483
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of probable bemiparin-induced heparin-induced thrombocytopenia type II managed with low-dose fondaparinux.
    Koul AN
    J Postgrad Med; 2015; 61(4):267. PubMed ID: 26440400
    [No Abstract]   [Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
    Baroletti S; Piovella C; Fanikos J; Labreche M; Lin J; Goldhaber SZ
    Thromb Haemost; 2008 Dec; 100(6):1130-5. PubMed ID: 19132240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism.
    Stein PD; Hull RD; Matta F; Yaekoub AY; Liang J
    Am J Med; 2009 Oct; 122(10):919-30. PubMed ID: 19682670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heparin-induced thrombocytopenia: implictions for cardiologist].
    Mattioli AV
    G Ital Cardiol (Rome); 2006 Oct; 7(10):675-83. PubMed ID: 17171989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombocytopenia associated with low-molecular-weight heparin.
    Lancet; 1991 Nov; 338(8776):1217. PubMed ID: 1682634
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings.
    Hull RD
    Thromb Haemost; 2008 Mar; 99(3):502-10. PubMed ID: 18327398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A benchmark for platelet count monitoring with low-molecular-weight heparin: expanding implementation of National Patient Safety Goals.
    Spinler SA
    Ann Pharmacother; 2009 Sep; 43(9):1519-21. PubMed ID: 19690223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay.
    Bryant A; Low J; Austin S; Joseph JE
    Br J Haematol; 2008 Dec; 143(5):721-6. PubMed ID: 19036016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.
    Alsaleh KA; Al-Nasser SM; Bates SM; Patel A; Warkentin TE; Arnold DM
    Am J Hematol; 2008 Nov; 83(11):876-8. PubMed ID: 18803278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
    Caprini JA
    Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
    [No Abstract]   [Full Text] [Related]  

  • 34. Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia.
    Chan M; Malynn E; Shaz B; Uhl L
    Am J Hematol; 2008 Mar; 83(3):212-7. PubMed ID: 17910041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low molecular weight heparin and bleeding in patients with chronic renal failure.
    Crowther M; Lim W
    Curr Opin Pulm Med; 2007 Sep; 13(5):409-13. PubMed ID: 17940486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of low-molecular-weight heparins in pregnancy--how safe are they?
    Deruelle P; Coulon C
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.
    Ban-Hoefen M; Francis C
    Thromb Res; 2009 Jun; 124(2):189-92. PubMed ID: 19195684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary embolism.
    Humenberger M; Lang IM
    Hamostaseologie; 2008 Feb; 28(1-2):40-3. PubMed ID: 18278161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Massive pulmonary embolism disclosing thrombocytopenia induced by low molecular weight heparin. Therapeutic success of prostacyclin].
    Metz D; N'Guyen P; Chapoutot L; Graciet J; Taupin JM; Grentzinger A; Elaerts J; Bajolet A
    Ann Cardiol Angeiol (Paris); 1991 Dec; 40(10):619-21. PubMed ID: 1723582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.